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Clinical Nephrotoxins, Renal Injury from Drugs and
Chemicals. Edited by Mark E de Broc, George A Porter,
William M Bennett and Gert A Verpooten. Kluwer
Academic Publishers. ISBN 0 7923 3611 9; pp 481; £160.
De Broc and colleagues have set out to produce a
comprehensive handbook ofchemical injury to the kidneys.
The work is divided into three parts: a general section,
dealing with clinical relevance, renal handling of drugs,
immunological and cellular mechanisms, and a detailed
exposition of experimental models; the main body of the
work, discussing specific drugs; and a section on prevention
including chapters on urinary biomarkers and principles and
practice of drug dosing.
The central body of the work is split into 25 short chapters
addressing individual drugs or groups ofdrugs. This section
alsoincludesfourbriefintroductions toanti-infectious agents,
analgesic related renal injury, immunosuppressive drugs and
environmental nephrotoxins. The order of the chapters is
necessarily arbitrary but occasionally confusing. The
introduction and four individual chapters on environmental
nephrotoxins, for instance, are inserted between discussions
ofcontrastassociatednephropathy andlithiumandthekidney.
A chapter on Balkan nephropathy, thought but not proved to
be caused by one or more environmental toxins, is tagged on
to the end of the section.
Despite the scope ofthe book there are several areas treated
skimpilyorignoredaltogether. Thustheimportantassociation
between long term lithium therapy and hyperparathyroidism
ratesexactlythreeunreferenced linesoftext. Therelationship
between triamterene and interstitial nephropathy receives
little more attention, although references are given. There is
a chapter on ACE inhibitors but no mention of ATI receptor
blockers. The only anticancer drugs examined are cisplatin
and carbiplatin; there is no discussion of the tumour lysis
syndrome, and an opportunity for practical guidance on an
important area of clinical nephrology is therefore lost. The
chapter onbetalactam antibiotics is exactlyhalfthelengthof
the discussion of amphotericin B. Organic solvents, silicon
compounds and pesticides are covered together in just 12
pages andthereisnoinformationonacutepoisoningwithany
of these agents. These problems are compounded by a
hopelessly inadequate index ofjust three pages.
The workwill be ofmore interest to practising nephrologists
than to clinical toxicologists and its worth may have been
greater if the attempt to cover environmental as well as
therapeutic agents had been abandoned. It will nevertheless
be a valuable guide to practical aspects of drug dosing and
toxicity in nephrology. The final section on drug doses, in
particular, will be a great help to nephrologists both in
training andcareergrades (althoughinformation ondosingin
continuous haemofiltration would have been useful). The
manual is likely to find a place on all busy renal units.
PETER GARRETT
C) The Ulster Medical Society, 1999.
Normal and Malignant Liver Cell Growth. Edited by N E
Fleig. Kluwer Academic Publishers. ISBN 0792387481.
£105
The mechanisms governing normal proliferation and
malignant transformation of liver cells are crucial to the
understanding ofregeneration andhepatocarcinogenesis. The
liver has a huge capacity to regenerate following damage by
variousviruses andtoxins. Primaryhepatocellularcarcinoma
is one of the most frequent malignancies world wide.
Knowledge in these areas has expanded in recent years and
this book details the Proceedings of the International Falk
Workshop, Halle, Germany, 1998 which focused on the
issues of normal and malignant liver cell growth. Recent
advances in basic science and clinical research in these areas
are presented. There is also stimulating discussions from an
international panel of experts concerning strategies for
development in diagnosis and treatment of hepatoma and
regenerationinthosepatientswithacuteandchronicfunctional
loss of liver tissue.
This is a book which will be of more interest to specialists
undertaking research in this area rather than the practising
physician/hepatologist, however, the considerable spectrum
ofviewspresented frombasic sciencetoclinical applications
should help clinicians to understand the principles of liver
cell regeneration and carcinogenesis and also the basic
scientists to understand some of the important clinical
observations and questions. This may stimulate further
relevantresearchbybringingbedsidequestionstobeaddressed
at the laboratory bench.
F A O'CONNOR
Innovative Concepts in Inflammatory Bowel Diseases.
EditedbyJEmmrich, SLiebe,EFStange. KluwerAcademic
Publishers. ISBN 0792387 49X. £125
Chronicinflammatoryboweldiseases (IBD) arecommonand
thecause(s)unknown.Althoughthereareeffectivetreatments
these have to be administered in a largely empirical way and
perhaps more than any other conditions in gastroenterology
require a good deal of experience on the part of the doctor.
Thisbookpresentsthepapersfromaninternationalconference
that took place in May 1998 in Rostock on the basic and
clinical aspects of inflammatory bowel disease. The main
themes of the meeting were genetics, animal models,
immunology, epithelial cells, endotoxin, diagnostic
procedures, malignancy, medical therapies and surgery.
The book stretches to 359 pages with the first 215 devoted to
experimental data on the possible causes and mechanisms of
disease. No definitive aetiology emerged but there were lots
ofinteresting findings. Itprovides much food forthought for
any researchers who want to know the current state of
knowledgeandtodecidewhatareatheymightmostprofitably
explore themselves. Our own Mr Keith Gardiner from the
Queen's University Department of Surgery has written a
chapter on the detection ofendotoxin in IBD. The chapter on
autoantibodies in IBD includes a useful examination of the
data .on antibodies to neutrophils (pANCA), a test which is
makingits way into clinicalpractice. Somecontributors have
helpfullyprovided asummary attheendoftheirchapters. For
the non specialist it would have been helpful ifevery authorBook Reviews
had done this. Also no doubt there was very lively debate
about the relative validity and importance of the different
experimental approaches covered. The reader is presented
with awhole range ofinformation, all ofwhich appears to be
ofequalvalidity (perhaps deliberately so). Itmighthavebeen
helpful ifthe editors hadreported some ofthe discussion and
highlighted the area(s) considered to be most promising.
The second part of the book deals with clinical aspects of
IBD: diagnosis, IBD and malignancy, and therapy in IBD.
The most novel issues were a chapter on the association of
pancreatitis and Crohn's disease, and another on the use of
colonic lavage fluid to look for K-ras and p53 mutations as
indicators of malignancy in long standing IBD. The section
on therapy adequately covered all the appropriate areas,
medical and surgical, based on the available literature. There
was also a consideration of alternative treatments such as
nicotine, which was effectively dismissed. Dr Present from
Mount Sinai Medical Center, New York, wrote the first
chapter in this section and expressed his personal view that
steroids should not be used as frequently as at present and
would in time become a third-line agent for active Crohn's
disease behind immunomodulators and immunobiological
therapies such as anti TNF-ax antibody. Although such views
were not "evidence based" his ideas were the result of very
sound clinical experience and rather refreshing. As with the
first section a commentary by the editors on the issues
discussed and any consensus wouldhave been very valuable.
In summary a more useful book for the scientist than the
clinician, who muststilldeal withtheseconditions asbesthe/
she can in an empirical way. There were however some
genuinely novel pointers for the future.
PETER WATSON
i The Ulster Medical Society, 1999.
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